Functional consequences of abnormal Cx43 expression in the heart.

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cardiac Electrophysiology

Background:

• Connexin43 (Cx43) is the primary gap junction protein in the heart.
• Cx43 expression is altered in various cardiomyopathies, typically down-regulated and redistributed.
• Impaired Cx43 contributes to cardiac dysfunction and electrical instability.

Purpose of the Study:

• To review Cx43 remodeling in hypertrophic, dilated, and ischemic cardiomyopathy.
• To examine the functional consequences of altered Cx43 expression.
• To discuss therapeutic strategies targeting Cx43.

Main Methods:

• Review of existing literature on Cx43 in cardiac disease.
• Analysis of functional impacts of Cx43 alterations.
• Discussion of therapeutic interventions and their outcomes.

Main Results:

• Reduced and heterogeneous Cx43 expression correlates with slowed conduction, dispersed impulse conduction, and arrhythmias.
• Cx43 remodeling interacts with cardiac fibrosis.
• Therapies enhancing Cx43 show anti-arrhythmic potential in heart failure but may increase infarct size in acute ischemia.

Conclusions:

• Cx43 remodeling is a key feature of diseased hearts with significant functional consequences.
• Targeting Cx43 offers potential therapeutic avenues for arrhythmias in heart failure.
• Careful consideration of therapeutic timing and context is crucial, especially in acute ischemia, due to potential trade-offs with infarct size.